ArticleAnimals : an open access journal from MDPI2023

In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma.

Georgina A Cardama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.